{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:51:19Z","timestamp":1794711079822,"version":"4.9.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116433","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T15:37:02Z","timestamp":1710862622000},"page":"116433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases"],"prefix":"10.1016","volume":"174","author":[{"given":"Mohammad Reza","family":"Arabestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Bigham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Kamarehei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahya","family":"Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Gorjikhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-504X","authenticated-orcid":false,"given":"Seyed Mostafa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib1","first-page":"259","article-title":"Solid lipid nanoparticles (SLN) as a novel drug delivery system: a theoretical review","volume":"11","author":"Alsaad","year":"2020","journal-title":"Syst. Rev. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib2","first-page":"8","article-title":"Solid lipid nanoparticles-a review","volume":"5","author":"Yadav","year":"2013","journal-title":"Int J. Appl. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib3","first-page":"67","article-title":"Solid lipid nanoparticles: a review","volume":"4","author":"Lingayat","year":"2017","journal-title":"Nanosci. Nanotechnol. Res."},{"issue":"45","key":"10.1016\/j.biopha.2024.116433_bib4","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.biopha.2024.116433_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003467","article-title":"Emerging infectious diseases: threats to human health and global stability","volume":"9","author":"Morens","year":"2013","journal-title":"PLOS Pathog."},{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1108296","article-title":"The perpetual challenge of infectious diseases","volume":"366","author":"Fauci","year":"2012","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116433_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.micinf.2015.01.004","article-title":"How bacterial pathogens colonize their hosts and invade deeper tissues","volume":"17","author":"Ribet","year":"2015","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.biopha.2024.116433_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/MMBR.00063-12","article-title":"Type IV Pili in gram-positive bacteria","volume":"77","author":"Melville","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6018","key":"10.1016\/j.biopha.2024.116433_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1126\/science.1200729","article-title":"Posttranslational modification of Pili upon cell contact Triggers N. meningitidis dissemination","volume":"331","author":"Chamot-Rooke","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the Natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116433_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.chembiol.2012.10.022","article-title":"Molecular basis of in vivo biofilm formation by bacterial pathogens","volume":"19","author":"Joo","year":"2012","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2024.116433_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1080\/03639045.2018.1506472","article-title":"Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis","volume":"44","author":"Chokshi","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1040841X.2020.1843399","article-title":"Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections","volume":"47","author":"Araujo","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2024.116433_bib16","doi-asserted-by":"crossref","unstructured":"Prastiwi N., Lesbatta K. Application of solid lipid nanoparticles preparation in infection caused by antibiotic-resistant bacteria. Indonesian Journal of Pharmacology and Therapy.2(3).","DOI":"10.22146\/ijpther.2318"},{"key":"10.1016\/j.biopha.2024.116433_bib17","article-title":"Ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment","volume":"2017","author":"Shazly","year":"2017","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/nano11051251","article-title":"Incorporation of antibiotics into solid lipid nanoparticles: A promising approach to reduce antibiotic resistance emergence","volume":"11","author":"Arana","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.116433_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chemphyslip.2016.09.002","article-title":"Synthesis and optimization of ceftriaxone-loaded solid lipid nanocarriers","volume":"200","author":"Kumar","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/nano8050304","article-title":"A method for efficient loading of ciprofloxacin hydrochloride in cationic solid lipid nanoparticles: Formulation and microbiological evaluation","volume":"8","author":"Pignatello","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.116433_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2018.11.017","article-title":"Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides","volume":"134","author":"Gonz\u00e1lez-Paredes","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tvjl.2010.11.019","article-title":"Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo","volume":"191","author":"Wang","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.biopha.2024.116433_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2024.116433_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejps.2017.05.063","article-title":"Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy","volume":"106","author":"Severino","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13346-018-00607-w","article-title":"Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy","volume":"9","author":"Maretti","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib26","first-page":"1","article-title":"Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116433_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112938","article-title":"Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa","volume":"488","author":"Afshari","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2024.116433_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9571286","article-title":"Experimental Study on the Resistance of Synthetic Penicillin Solid Lipid Nanoparticles to Clinically Resistant Staphylococcus aureus","volume":"2021","author":"Zhao","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.biopha.2024.116433_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114116","article-title":"Use of the quantum dot-labeled solid lipid nanoparticles for delivery of streptomycin and hydroxychloroquine: A new therapeutic approach for treatment of intracellular Brucella abortus infection","volume":"158","author":"Karimitabar","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib30","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/1750-3841.15732","article-title":"Optimization and antimicrobial efficacy of curcumin loaded solid lipid nanoparticles against foodborne bacteria in hamburger patty","volume":"86","author":"Alanchari","year":"2021","journal-title":"J. Food Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-019-0504-8","article-title":"Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella melitensis enclosed in macrophage: a pharmacodynamics study on J774A. 1 cell line","volume":"8","author":"Hosseini","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"10.1016\/j.biopha.2024.116433_bib32","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.2147\/IJN.S168179","article-title":"Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies","volume":"13","author":"Zhu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.biopha.2024.116433_bib33","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/polym14122436","article-title":"Shea Butter Potentiates the Anti-Bacterial Activity of Fusidic Acid Incorporated into Solid Lipid Nanoparticle","volume":"14","author":"Elsewedy","year":"2022","journal-title":"Polymers"},{"issue":"7","key":"10.1016\/j.biopha.2024.116433_bib34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/10837450.2020.1744008","article-title":"Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN)","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.biopha.2024.116433_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2021.105086","article-title":"A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles","volume":"237","author":"Amasya","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biopha.2024.116433_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.biopha.2024.116433_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/03639040802130061","article-title":"Lipid nanoparticles with a solid matrix (SLN\u00ae, NLC\u00ae, LDC\u00ae) for oral drug delivery","volume":"34","author":"Muchow","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2024.116433_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/03639045.2020.1775632","article-title":"Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study","volume":"46","author":"Routray","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejpb.2011.02.009","article-title":"Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration","volume":"79","author":"Priano","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.116433_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116433_bib42","first-page":"1848","article-title":"Solid lipid nanoparticles for oral delivery of poorly soluble drugs","volume":"4","author":"Jawahar","year":"2012","journal-title":"J. Pharm. Sci. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116433_bib43","article-title":"Solid lipid nanoparticles (SLN'S)-trends and implications in drug targeting","volume":"1","author":"Sinha","year":"2010","journal-title":"Int. J. Adv. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116433_bib44","first-page":"928","article-title":"Solid lipid nanoparticles: a review","volume":"4","author":"Hanumanaik","year":"2013","journal-title":"Int J. Pharm. Sci. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.colsurfb.2007.07.015","article-title":"Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system","volume":"61","author":"Yuan","year":"2008","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"37","key":"10.1016\/j.biopha.2024.116433_bib47","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2174\/1381612825666190903155321","article-title":"Solid lipid nanoparticles: a promising nanomaterial in drug delivery","volume":"25","author":"Rajpoot","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijpharm.2013.08.070","article-title":"A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles","volume":"456","author":"Zariwala","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116433_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111305","article-title":"Solid lipid nanoparticles for enhanced oral absorption: A review","volume":"196","author":"Salah","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"7","key":"10.1016\/j.biopha.2024.116433_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.116433_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.01.010","article-title":"Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms","volume":"201","author":"De Jesus","year":"2015","journal-title":"J. Control. Release"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116433_bib52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib53","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1166\/jbn.2014.1776","article-title":"Uptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatoma","volume":"10","author":"Wang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib56","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.copbio.2011.06.003","article-title":"Polymer\u2013drug conjugates as nano-sized medicines","volume":"22","author":"Canal","year":"2011","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116433_bib57","first-page":"2187","article-title":"Nano\/micro-assisted regenerative medicine","author":"Choi","year":"2018","journal-title":"MDPI"},{"key":"10.1016\/j.biopha.2024.116433_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.640182","article-title":"Nano-medicine in the cardiovascular system","volume":"12","author":"Pretorius","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116433_bib59","series-title":"Vaccine Design","first-page":"355","article-title":"Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines","author":"Francis","year":"2022"},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib60","article-title":"Solid lipid nanoparticles: Vital characteristics and prospective applications in cancer treatment","volume":"36","author":"Laz\u0103r","year":"2019","journal-title":"Crit. Rev. \u2122 Ther. Drug Carr. Syst."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-02186-5","article-title":"Transdermal delivery of curcumin-loaded solid lipid nanoparticles as microneedle patch: an in vitro and in vivo study","volume":"23","author":"Prabhu","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2024.116433_bib62","article-title":"Preparation and characterization of magnetic solid lipid nanoparticles as a targeted drug delivery system for doxorubicin","author":"Soltani","year":"2022","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2024.116433_bib63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ijbiomac.2021.11.161","article-title":"Formulation and characterization of hydroxyethyl cellulose-based gel containing metronidazole-loaded solid lipid nanoparticles for buccal mucosal drug delivery","volume":"194","author":"Ho","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116433_bib64","first-page":"683","article-title":"Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design","volume":"6","author":"Hao","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/gels8010058","article-title":"Self-gelling solid lipid nanoparticle hydrogel containing simvastatin as suitable wound dressing: an investigative study","volume":"8","author":"Gupta","year":"2022","journal-title":"Gels"},{"issue":"2","key":"10.1016\/j.biopha.2024.116433_bib66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/pharmaceutics14020240","article-title":"Vine cane compounds to prevent skin cells aging through solid lipid nanoparticles","volume":"14","author":"Pereira","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116433_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.120909","article-title":"Polymethine dyes-loaded solid lipid nanoparticles (SLN) as promising photosensitizers for biomedical applications","volume":"271","author":"Chinig\u00f2","year":"2022","journal-title":"Spectrochim. Acta Part A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.biopha.2024.116433_bib68","first-page":"1","article-title":"Studies in development and statistical optimization of levofloxacin solid lipid nanoparticles for the treatment of tuberculosis","author":"Shah","year":"2022","journal-title":"J. Pharm. Innov."},{"issue":"1","key":"10.1016\/j.biopha.2024.116433_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2024.116433_bib70","series-title":"Controlled Drug Delivery Concepts and Advances","first-page":"411","author":"Vyas","year":"2002"},{"key":"10.1016\/j.biopha.2024.116433_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.571040","article-title":"Nanocarriers from natural lipids with in vitro activity against Campylobacter jejuni","volume":"10","author":"Ribeiro","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2024.116433_bib72","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","article-title":"Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment","volume":"121","author":"Jain","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"6","key":"10.1016\/j.biopha.2024.116433_bib73","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/jbm.a.34467","article-title":"Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops","volume":"101","author":"Abul Kalam","year":"2013","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib74","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1166\/jbn.2011.1332","article-title":"AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration","volume":"7","author":"Patel","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116433_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/molecules27051543","article-title":"Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems","volume":"27","author":"Madkhali","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116433_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105721","article-title":"Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug resistant microbes and biofilm-associated infections","author":"Elfadil","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biopha.2024.116433_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.micpath.2015.11.031","article-title":"Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm","volume":"93","author":"Bazzaz","year":"2016","journal-title":"Microb. Pathog."},{"issue":"11","key":"10.1016\/j.biopha.2024.116433_bib78","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/pharmaceutics12111093","article-title":"Formulation of pH-responsive quatsomes from quaternary bicephalic surfactants and cholesterol for enhanced delivery of vancomycin against methicillin resistant Staphylococcus aureus","volume":"12","author":"Hassan","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:47:40Z","timestamp":1782341260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":78,"alternative-id":["S0753332224003172"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116433","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116433"}}